一个多中心的2期临床试验,低剂量皮下注射decitabine用于骨髓纤维化
Chenyu Lin1, Anand A Patel2, Dezheng Huo3
1The University of Chicago Pritzker School of Medicine, Chicago, IL.
Blood advances
|September 9, 2024
概括
在骨髓纤维化患者中,皮下注射的德西他显示出33%的应答率,改善了血液细胞计数. 建议对这种具有挑战性的血液性恶性瘤进行进一步研究.
科学领域:
- 血液学 血液学 血液学
- 在瘤学瘤学.
- 药理学 药理学是指药理学的学科.
背景情况:
- 骨髓纤维化 (MF) 带来了重大治疗挑战,目前的治疗主要集中在症状管理上.
- 对于MF,有效的治疗选择有限,特别是对于患有严重细胞衰竭的患者.
研究的目的:
- 评估皮下注射德丁在患有骨髓纤维化症的患者的疗效和安全性.
- 确定与多发性肺炎患者对德西他治疗反应相关的因素.
主要方法:
- 一个前性的,多中心的2期临床试验,涉及21名骨髓纤维化患者.
- 患者接受了0.3毫克/公斤/天的皮下滴滴10天的治疗方案.
主要成果:
- 总体应答率为33%,主要以细胞衰竭的改善为特征.
- 响应的平均持续时间为7个月. 与反应相关的因素包括国际预后评分系统的高风险,胎儿血红蛋白升高和CD34+细胞数量的减少.
- 三四级细胞衰竭是常见的;像疲劳和低血症这样的非血液毒性较少发生.
结论:
- 德西塔显示出作为髓纤维化治疗剂的潜力,特别是在改善细胞衰竭方面.
- 在MF中,需要对低甲基化剂,包括德西他,进行进一步的研究,可能在组合疗法中.
- 这项研究支持对患有重度细胞衰竭的多发性纤维炎患者进行探讨,解决未满足的治疗需求.
相关概念视频
Bioavailability Study Design: Single Versus Multiple Dose Studies
47
Bioavailability studies are essential for understanding how a drug is absorbed, distributed, metabolized, and excreted in the body. These studies assess the extent and rate at which the active pharmaceutical agent becomes available at the site of action. The design of bioavailability studies can involve single-dose or multiple-dose regimens, each with distinct advantages and limitations.Single-dose studies are the preferred approach due to their simplicity and reduced drug exposure for...
47
Bioavailability Study Design: Healthy Subjects Versus Patients
34
Bioavailability studies are essential for evaluating a drug's therapeutic efficacy and understanding its absorption patterns under various physiological conditions. Conducting such studies on target patient populations provides more relevant data by simulating real-world disease states. However, practical challenges often necessitate the use of young, healthy adult volunteers as study subjects.Patients may exhibit altered drug absorption patterns due to the effects of the disease itself,...
34
Drug Accumulation During Multiple Dosing: Intermittent IV Infusions
63
Intermittent intravenous (IV) infusion is a method of drug administration where medications are delivered over short infusion periods followed by intervals of no drug delivery. This approach helps to prevent sustained high drug concentrations in the bloodstream, reducing the risk of adverse effects associated with prolonged exposure. Unlike continuous infusion, steady-state concentrations may not be achieved during a single dosing cycle but can be reached through repeated...
63
Clinical Trials
9.9K
Clinical trials are prospective experimental studies conducted on humans to determine the safety and efficacy of treatments, drugs, diet methods, and medical devices. Using statistics in clinical trials enables researchers to derive reasonable and accurate conclusions from the collected data, allowing them to make wise decisions in uncertain situations. In medical research, statistical methods are crucial for preventing errors and bias.
There are four phases in a clinical trial. A phase one...
There are four phases in a clinical trial. A phase one...
9.9K
Clinical Trials: Overview
4.0K
Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
4.0K
Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents
299
Crohn's disease is an inflammatory bowel disorder marked by chronic inflammation of the GI tract. Various treatment strategies for Crohn's disease are employed, such as immunomodulatory agents, glucocorticoids, and biologics or anti-TNF therapy. Azathioprine (Imuran), a commonly used immunomodulatory drug for Crohn's disease, is converted in the body to mercaptopurine, which inhibits purine biosynthesis and cell proliferation. Both are utilized in severe cases of Inflammatory Bowel...
299


